Sneha K

1 week ago | conexiant.com | Sneha K |Mariam Sunny

The CDC’s vaccine advisory committee is expected to vote on expanding access to RSV vaccines during the second session of its meeting. Guidelines from the Advisory Committee on Immunization Practices (ACIP) inform clinician decision-making and influence insurance coverage determinations in the U.S.Three RSV vaccines have been approved by the U.S. Food and Drug Administration: GSK’s Arexvy, Moderna’s mRESVIA, and Pfizer’s Abrysvo.

1 week ago | marketscreener.com | Mariam Sunny |Sneha K

(Reuters) -The U.S. Centers for Disease Control and Prevention's outside panel of vaccine experts on Tuesday discussed narrowing recommendations on the use of COVID-19 booster shots for the upcoming immunization campaign in its first meeting under the new Trump administration. The panel raised the idea of recommending the updated vaccine only for vulnerable populations at risk of severe COVID-19 for the 2025-2026 season.

1 week ago | yahoo.com | Mariam Sunny |Sneha K

April 15 (Reuters) - The U.S. Centers for Disease Control and Prevention's outside expert panel began a two-day meeting on April 15 after a nearly two-month delay during which it will review guidelines for several vaccines and discuss narrowing recommendations on COVID-19 booster shots. The panel will vote on April 16 about recommendations for three vaccines, including for respiratory syncytial virus and chikungunya, a mosquito-borne disease.

1 week ago | streetinsider.com | Mariam Sunny |Sneha K

By Mariam Sunny and Sneha S K (Reuters) -The U.S. Centers for Disease Control and Prevention's outside panel of vaccine experts on Tuesday discussed narrowing recommendations on the use of COVID-19 booster shots for the upcoming immunization campaign in its first meeting under the new Trump administration. The panel raised the idea of recommending the updated vaccine only for vulnerable populations at risk of severe COVID-19 for the 2025-2026 season.

1 week ago | today.westlaw.com | Manas Mishra |Sneha K |Bill Berkrot |Mariam Sunny

(Reuters) - The U.S. Centers for Disease Control and Prevention's outside expert panel began a two-day meeting on Tuesday after a nearly two-month delay during which it will review guidelines for several vaccines and discuss narrowing recommendations...